Council Members in this Study Group: 804
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Kevin KearnsPresident, Managing Partner
2K Healthcare Solutions![]()
Kevin Kearns, MD, is a board certified internist with a diverse background in academic medicine, clinical practice, health system medical management and managed care. Dr. Kearns has been Managing Partner for 2K Healthcare Solutions since February 2009....
Principal
Tarplin Strategies, LLC![]()
Richard Tarplin is Founder of Tarplin Strategies, LLC in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and healthcare sectors. He served for almost 20 years in the US House of Representatives,...
David ZimmermanPresident/Owner
Doctors of Pharmacy, Inc.![]()
David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at EHIM, a pharmacy benefit manager. He has over 30 years of experience, specializing...
Stan SchofieldVice President
MAINEHEALTH![]()
Stan Schofield is the President of NorDx, a regional laboratory corporation within the Maine Health System. He also serves as Vice President and Senior Member of the Health System Executive Management Team. Mr. Schofield is the Founder and Managing Principal...
John WaughVice President, Laboratory
HENRY FORD HEALTH SYSTEM![]()
John Waugh is Vice President of Laboratory at Henry Ford Health System, one of the top US laboratories. Mr. Waugh has expertise in purchasing and evaluating new and emerging clinical and molecular diagnostics including, but not limited to, systems from...
June 26, 2008 | Palo Alto
GLG Seminar: Molecular Platforms and Laboratory TechnologyAugust 21, 2007 | New York
GLGi: Disease ManagementJuly 31, 2007 | Boston
GLGi: Managed Care FormularyTeleconference: Grifols/Talecris - Competitive Implications (11:00 AM EDT/ 16:00 BST)
6/9/2010